This is the limited version of the Vertex Pharmaceuticals company profile: Join LinkedIn or Sign In to see more information.
Small molecule drug discovery in disease areas for which patients need new and better drugs. The first drugs to market for Vertex were Agenerase and Lexiva, both targeting HIV protease. Current focus is on HCV and CF, both diseases in need of improved medicines
Your Connections to Vertex Pharmaceuticals
Popular Profiles at Vertex Pharmaceuticals
New Hires and Recent Promotions at Vertex Pharmaceuticals
-
Doug McConnell, Sr. Director of Strategic Development Networks
was Sr. Dir. MDG Business Operations - last month
-
was Sr. Financial Analyst, Business Development - 2 months ago
-
was Staffing Coordinator, University Relations. - 2 months ago
-
Mark Bruce, Senior Clinical Project Manager
was Clinical Project Manager - 3 months ago
-
was Clinical Trials Coordinator - 3 months ago
Jobs at Vertex Pharmaceuticals
Last edited by VP-Drug Innovation at Vertex pharmaceuticals
Vertex Pharmaceuticals Inc
130 Waverly Street
Cambridge, MA
02139
United States
Phone: 617-444-6100
Fax: 617-576-2109
| Headquarters | Greater Boston Area |
| Industry | Pharmaceuticals |
| Type | Public Company |
| Status | Operating |
| Company Size |
1,200 employees
|
| 2006 Revenue |
$216
mil
(34%)
|
| Founded | 1989 |
| Website | http://www.vrtx.com |
Estimated based on LinkedIn Data
Career path for Vertex Pharmaceuticals employees
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Vertex Pharmaceuticals. This page is not endorsed by or affiliated with Vertex Pharmaceuticals. For questions regarding LinkedIn Company Profiles, contact us.
Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions